Search

Investor Centre
FAQ

MXC: $0.027

Search

Skip to content

MENUMENU

Who We Are
What We Do
Why Invest
Contact us

ASX Announcements

ASX Announcements
Financial Reports
Presentations
Research Reports & Publications
Shareholder Info
Corporate Governance

ASX Announcements

ASX: MXC

$0.027

Sunday, 17 January 2021

Latest Announcements

13/1/21Key Appointment - Global Chief Sales Officer 22/12/20Appendix 2A 22/12/20MGC Pharma to receive grant for Malta production facility 15/12/20ArtemiC Phase II Clinical Trial Results 11/12/20Appendix 2A 9/12/20Completion of Unmarketable Parcel Share Sale Facility 7/12/20ArtemiC Phase II Clinical Trial Results Update

I'd like to opt-in to receive:
All updates

Announcements and News

Investor Presentations

Leave this field empty if you're human:

Pharma Corporate & Financial Headquarters

Pharma European Operational Headquarters

UK

European Corporate Headquarters

Who

Our Team
We believe
Where we are

What

We research
We produce
We develop

Why

ASX Announcements
Financial Reports
Research Reports & Publications
Shareholder Info
Corporate Governance

Privacy Policy Cookie Policy Disclaimer

© MGC Pharma 2021. All Rights Reserved.

Experience by Interactive Investor

Home
Who We Are
What We Do
Why Invest
FAQ
Contact Us